Removal of the Active Pharmaceutical Substance Entecavir from Water via the Fenton Reaction or Action by the Cyanobacterium Microcystis novacekii
- PMID: 39771100
- PMCID: PMC11679440
- DOI: 10.3390/toxics12120885
Removal of the Active Pharmaceutical Substance Entecavir from Water via the Fenton Reaction or Action by the Cyanobacterium Microcystis novacekii
Abstract
Entecavir (ETV) is an antiviral used to treat chronic infection caused by the hepatitis B virus, which affects approximately 250 million people worldwide. In order to mitigate the impacts of ETV on the environment, including potential harm to human health, this study evaluated the use of the Fenton-like reaction, which uses iron complexed with ethylenediaminetetraacetic acid (EDTA) at neutral pH, and the microbiological action of Microcystis novacekii in removing ETV from the aqueous medium. Aqueous concentrations of 100 mg/L were subjected to Fenton-like degradation. Solutions ranging from 1.2 to 120 mg/L were used for biodegradation. The results evidenced consistent effectiveness in completely removing ETV by the Fenton-like reaction after 90 s. However, removal by the action of M. novacekii did not return convincing results. Although entecavir exposure did not affect cyanobacterial cell growth, a gradual reduction in drug content was observed starting on the fourth day of exposure, with maximum removal of 28.9% at the lowest exposure concentration (1.2 mg/L), without, however, showing a significant difference. Statistically significant differences in drug removal were identified only after 14 days of exposure and at specific concentrations. The ETV degradation process through the Fenton reaction was effective and promising for practical application. Removal through M. novacekii showed limited efficacy for practical application for its direct use in the remediation of ETV in aquatic environments. However, we identified a slight decrease in the initial concentrations that could achieve greater efficiency in the drug's degradation through associations with other microorganisms, physiochemical processes, or even genetic engineering.
Keywords: Fenton-like reaction; Microcystis; cyanobacteria; degradation; entecavir.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Evaluation of the capacity of the cyanobacterium Microcystis novacekii to remove atrazine from a culture medium.J Environ Sci Health B. 2013;48(2):101-7. doi: 10.1080/03601234.2013.726891. J Environ Sci Health B. 2013. PMID: 23305277
-
Removal of methyl parathion by cyanobacteria Microcystis novacekii under culture conditions.J Environ Monit. 2010 Jun;12(6):1302-6. doi: 10.1039/b923288e. Epub 2010 Mar 19. J Environ Monit. 2010. PMID: 20532383
-
Removal of 17α-ethinylestradiol from a sterile WC medium by the cyanobacteria Microcystis novacekii.J Environ Monit. 2012 Sep;14(9):2362-6. doi: 10.1039/c2em30320e. Epub 2012 Jul 13. J Environ Monit. 2012. PMID: 22796719
-
Recent progress in Fenton/Fenton-like reactions for the removal of antibiotics in aqueous environments.Ecotoxicol Environ Saf. 2022 May 1;236:113464. doi: 10.1016/j.ecoenv.2022.113464. Epub 2022 Apr 5. Ecotoxicol Environ Saf. 2022. PMID: 35395600 Review.
-
The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis.BMC Gastroenterol. 2020 Oct 19;20(1):348. doi: 10.1186/s12876-020-01477-8. BMC Gastroenterol. 2020. PMID: 33076834 Free PMC article.
References
-
- WHO . Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries. World Health Organization, Department of Global HIV, Hepatitis and Sexually Transmited Infections Programmes; Geneva, Switzerland: 2024. p. 239.
-
- Brasil . Viral Hepatitis Epidemiological Bulletin. Secretariat of Sanitary Surveillance/Ministry of Health; Brasília, Brazil: 2023.
Grants and funding
LinkOut - more resources
Full Text Sources